ADMS — ADAMAS PHARMACEUTICALS INC
ADMS (ADAMAS PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 20 funds have reported positions historically, with the sum of their latest reported stakes valued at $52.48M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q3 2021 | 5.45M | $26.76M | 0.00% | New |
| Vanguard Group history | Q3 2021 | 1.77M | $8.67M | 0.00% | Add |
| Point72 Asset Management history | Q3 2021 | 1.15M | $5.65M | 0.03% | New |
| Renaissance Technologies history | Q3 2021 | 763.21K | $3.75M | 0.01% | New |
| Geode Capital Management history | Q3 2021 | 360.74K | $1.77M | 0.00% | New |
| Two Sigma Investments history | Q3 2021 | 331.24K | $1.63M | 0.00% | New |
| D. E. Shaw & Co history | Q3 2021 | 293.43K | $1.44M | 0.00% | New |
| BNY Mellon history | Q3 2021 | 128.35K | $630.00K | 0.00% | New |
| Northern Trust Corp history | Q3 2021 | 102.99K | $506.00K | 0.00% | New |
| Morgan Stanley history | Q3 2021 | 67.12K | $329.00K | 0.00% | New |
| Bank of America Corp history | Q3 2021 | 66.75K | $328.00K | 0.00% | New |
| Principal Global Investors history | Q3 2021 | 63.17K | $310.00K | 0.00% | New |
| Citadel Advisors history | Q3 2021 | 48.08K | $236.00K | 0.00% | New |
| Goldman Sachs Group history | Q3 2021 | 38.80K | $190.00K | 0.00% | New |
| T. Rowe Price Associates history | Q3 2021 | 26.00K | $128.00K | 0.00% | New |
| Charles Schwab Investment Management history | Q3 2021 | 17.87K | $88.00K | 0.00% | New |
| PNC Financial Services history | Q3 2021 | 13.00K | $64.00K | 0.00% | New |
| UBS Group AG history | Q3 2021 | 2.27K | $11.00K | 0.00% | New |
| Wells Fargo & Co history | Q3 2021 | 521 | $2.00K | 0.00% | New |
| JPMorgan Chase & Co history | Q3 2021 | 28 | $0 | — | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2021 | Q2 2021 | Q3 2021 |
|---|---|---|---|
| Fidelity Management & Research (FMR) | — | — | 5.45M |
| Vanguard Group | 1.72M | 1.75M | 1.77M |
| Point72 Asset Management | — | — | 1.15M |
| Renaissance Technologies | — | — | 763.21K |
| Geode Capital Management | — | — | 360.74K |
| Two Sigma Investments | — | — | 331.24K |
| D. E. Shaw & Co | — | — | 293.43K |
| BNY Mellon | — | — | 128.35K |
| Northern Trust Corp | — | — | 102.99K |
| Morgan Stanley | — | — | 67.12K |
| Bank of America Corp | — | — | 66.75K |
| Principal Global Investors | — | — | 63.17K |
| Citadel Advisors | — | — | 48.08K |
| Goldman Sachs Group | — | — | 38.80K |
| T. Rowe Price Associates | — | — | 26.00K |
| Charles Schwab Investment Management | — | — | 17.87K |
| PNC Financial Services | — | — | 13.00K |
| UBS Group AG | — | — | 2.27K |
| Wells Fargo & Co | — | — | 521 |
| JPMorgan Chase & Co | — | — | 28 |